MedPath

To compare the effectiveness of mobile App vs conventional prescription of analgesics and adjuvants on compliance, knowledge and satisfaction among advanced cancer patients receiving palliative care at a tertiary care centre.

Not Applicable
Conditions
Health Condition 1: D098- Carcinoma in situ of other specified sites
Registration Number
CTRI/2022/01/039354
Lead Sponsor
Payal Kahol
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Biopsy proven diagnosis of cancer

2.Advanced cancer patients in stage 3 or stage 4 of cancer

3.Advanced cancer patients receiving pain and palliative treatment at pain and palliative care clinic

4.Age > 18 yrs.

5.Patients with physician’s prescription of analgesics and adjuvants to treat cancer pain and other symptoms

6.Patients having accessibility to Android phone

7.Patients willing to participate in the study

Exclusion Criteria

1.Patients having symptoms such as pain, nausea, vomiting and constipation that is not related to cancer or cancer treatment

2.Life expectancy less than or equal to 6 months

3.Any known cognitive impairments or psychiatric illness

4.Patient or caregiver who are unable to read and understand English/Hindi language

5.Patient or caregiver who are unable to handle smart phone/mobile Apps

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath